Memorial Sloan-Kettering Cancer Center, IBM to Collaborate in Applying Watson Technology to Help Oncologists
Memorial Sloan-Kettering Cancer Center (MSKCC) and IBM (NYSE: IBM) have agreed to collaborate on the development of a powerful tool built upon IBM Watson in order to provide medical professionals with improved access to current and comprehensive cancer data and practices. The resulting decision support tool will help doctors everywhere create individualized cancer diagnostic and treatment and recommendations for their patients based on current evidence.
Holli HaswellIBM External RelationsUnited Stateshhaswell@us.ibm.com720-396-5485
MORE FROM Latest News
SUBSCRIBE TO RSS FEEDXML
IBM Predicts the Innovations that Will Most Change Our Lives, including the World's Smallest Computer
IBM Future of Identity Study: Millennials Poised to Disrupt Authentication Landscape
IBM Announces Collaboration with Leading Fortune 500 Companies, Academic Institutions and National Research Labs to Accelerate Quantum Computing